PILOPINE HS Drug Patent Profile
✉ Email this page to a colleague
When do Pilopine Hs patents expire, and when can generic versions of Pilopine Hs launch?
Pilopine Hs is a drug marketed by Alcon and is included in one NDA.
The generic ingredient in PILOPINE HS is pilocarpine hydrochloride. There is one drug master file entry for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the pilocarpine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pilopine Hs
A generic version of PILOPINE HS was approved as pilocarpine hydrochloride by INNOGENIX on December 22nd, 2004.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PILOPINE HS?
- What are the global sales for PILOPINE HS?
- What is Average Wholesale Price for PILOPINE HS?
Summary for PILOPINE HS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 66 |
| Patent Applications: | 5,746 |
| DailyMed Link: | PILOPINE HS at DailyMed |
US Patents and Regulatory Information for PILOPINE HS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcon | PILOPINE HS | pilocarpine hydrochloride | GEL;OPHTHALMIC | 018796-001 | Oct 1, 1984 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
